You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. BASELINE POTASSIUM CHANNELS AS THERAPEUTIC TARGETS

    SBC: Neurex Corp.            Topic: N/A

    N/A

    STTR Phase I 1998 Department of Health and Human Services
  2. N/A

    SBC: BOSTON MEDICAL PRODUCTS, INC.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  3. In Silico Prediction of Metabolic Gene Expression Patter

    SBC: GENOMATICA, INC.            Topic: N/A

    The recent explosion of biological information now available to researchers at all levels of biological investigation has resulted in-part from high-throughput technologies to sequence genes and proteins, and to determine their expression patterns, in an attempt to capture the algorithmic complexity of biological functions. Collectively, this data has begun to enable the study of cells as living s ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. INCREASING YIELDS FROM COMBINATORIAL LIBRARIES

    SBC: Chromaxome Corporation            Topic: N/A

    N/A

    STTR Phase I 1998 Department of Health and Human Services
  5. Training Simulation to Teach Alcohol Screening and Brief Intervention

    SBC: SIMMERSION LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Alcohol use disorders are common among primary care patients. They are also associated with serious adverse effects. Many health care professionals, however, often lack sufficient background in alcohol screening and brief intervention strategies to effectively help patients who use alcohol above recommended limits. In particular, they often lack the necessary i ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  6. Molecular Markers for Tissue Hypoxia

    SBC: NATURAL PHARMACIA INTERNATIONAL, INC.            Topic: N/A

    DESCRIPTION (PROVIDED BY APPLICANT): Hypoxia is important in cardiovascular disease and cancer, the two leading causes of death in the US. Studies of these and other diseases need a tool for following changes in tissue hypoxia. We propose the HypoxyprobeTM system of markers can meet this need. HypoxyprobeTM markers have advantages of high water solubility, chemical s ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  7. REMOTE EXPERT SCREENING FOR DIABETIC RETINOPATHY

    SBC: EYETEL CORPORATION            Topic: N/A

    N/A

    STTR Phase I 1999 Department of Health and Human Services
  8. Remote focusing through spatial light modulation for multifocal multiphoton micro

    SBC: BOULDER NONLINEAR SYSTEMS, INC.            Topic: NIMH

    DESCRIPTION (provided by applicant): Nonlinear optical microscopy techniques (such as two-photon florescence) are being used to acquire volumetric (i.e. three dimensional) images that probe several hundred microns into scattering tissue. These techniques are being combined with fast acquisition schemes to allow imaging of live, moving specimens at high NA. This combination allows for high-resoluti ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. High-throughput portable software for fragment-based drug design

    SBC: ACPHARIS            Topic: NIGMS

    DESCRIPTION (provided by applicant): Fragment-based drug design (FBDD) is a combinatorial approach in which individual fragments binding to regions of the target site are selected from a fragment library, and then combined to form potential lead compounds.Interest in this approach has significantly increased during the last few years, with many companies using FBDD methods based on X-ray crystallo ...

    STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Novel Therapy for Asthma Targeting beta-Adrenoceptors

    SBC: INVERSEON, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Asthma is a chronic inflammatory disease that effects approximately 17 million Americans. Despite the availability of inhaled beta-adrenoceptor (betaAR) agonists and corticosteroids, 1.8 million emergency room visits a year occur due to severe asthma attacks demonstrating a significant unmet medical need. The Company intends to develop and commercialize INV102, ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government